Form 4: Aclaris Therapeutics Executive Exercises Stock Options, Disposes of Shares for Tax Obligations
SEC Form 4 Filing
Joseph Monahan, Chief Scientific Officer of Aclaris Therapeutics, reports exercising restricted stock units and disposing of shares to cover tax obligations on March 1, 2025.
Summary
- On March 1, 2025, Joseph Monahan, the Chief Scientific Officer of Aclaris Therapeutics, exercised restricted stock units, acquiring 50,000 and 10,925 shares of common stock.
- Simultaneously, Monahan disposed of 27,258 shares to satisfy tax withholding obligations related to the vesting of these restricted stock units at a price of $1.99 per share.
- Following these transactions, Monahan directly owns 265,662 shares and indirectly owns 193 shares through his spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future performance of the company.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation matters.
Key Dates
| Date | Description |
|---|---|
| March 1, 2022 | Start date for vesting of shares underlying restricted stock units in four equal annual installments. |
| March 1, 2023 | Start date for vesting of shares underlying additional restricted stock units in four equal annual installments. |
| March 1, 2025 | Date of transaction: exercise of restricted stock units and disposal of shares for tax obligations. |
| March 4, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.